1030P Survival rates in high-risk neuroblastoma patients undergoing anti-GD2 immunotherapy: A single arm meta-analysis and systemic review.
Saved in:
| Title: | 1030P Survival rates in high-risk neuroblastoma patients undergoing anti-GD2 immunotherapy: A single arm meta-analysis and systemic review. |
|---|---|
| Authors: | Escalante Romero, L.1 (AUTHOR), Queiroz Costa Neto, I.2 (AUTHOR), Antunes, V.L.J.3 (AUTHOR), Matos Correia Rodrigues, M.1 (AUTHOR), Polo Mercado, J.R.4 (AUTHOR), Monteiro Caran, E.1 (AUTHOR) |
| Source: | Annals of Oncology. 2024 Supplement 2, Vol. 35, pS694-S695. 2p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2024.08.1089 |
